Senior Scientist I, DMPK jobs in United States
cer-icon
Apply on Employer Site
company-logo

Arrowhead Pharmaceuticals · 1 day ago

Senior Scientist I, DMPK

Arrowhead Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing innovative drugs for diseases with a genetic basis. They are seeking a Senior Scientist, DMPK to lead the design and execution of preclinical DMPK studies and ensure high-quality datasets that meet regulatory expectations.

BiotechnologyHealth CareNanotechnologyPharmaceutical
check
Comp. & Benefits
badNo H1Bnote

Responsibilities

Develop and implement in vitro and in vivo DMPK strategies to support preclinical development for compounds across multiple indications and routes of administration
Manage all DMPK activities, including oversight of internal resources and CRO partners to ensure high-quality and timely data delivery
Design, supervise, and execute preclinical PK studies, including non-compartmental analysis (NCA), data interpretation, reporting, and communication of PK/PD insights to project teams
Prepare and deliver IND-enabling DMPK packages, ensuring compliance with regulatory expectations and contributing to regulatory submissions
Apply working knowledge of GLP/GCP principles and ensure appropriate documentation for regulated studies
Support GLP toxicokinetic (TK) study design, analysis, and reporting
Oversee metabolite identification in preclinical and clinical samples using high-resolution mass spectrometry (HRMS)
Contribute to a dynamic, fast-paced DMPK team by offering scientific leadership, troubleshooting support, and cross-functional collaboration
Maintain a current understanding of clinical pharmacology literature and regulatory guidance for oligonucleotide/RNAi therapeutics

Qualification

DMPK expertisePhD in relevant fieldVitro ADME assaysLC–MS/MSHRMSDrug development experienceDrug biotransformationInterpersonal skillsCommunication skillsProblem-solving skills

Required

PhD in Pharmacometrics, Drug Metabolism, Pharmaceutical Sciences, or a related discipline with at least 3 years of industry experience
Deep and broad expertise in DMPK, with working knowledge of nucleotide or oligonucleotide drug metabolism and distribution highly desired
Hands-on experience with in vitro ADME assays, in vivo PK studies, drug–drug interaction (DDI) evaluations, and Phoenix WinNonlin
Experience with LC–MS/MS and HRMS, ideally applied to oligonucleotide therapeutics
Strong background in organic chemistry, biochemistry, and drug biotransformation
Demonstrated experience in drug development and understanding of regulatory processes
Excellent interpersonal, verbal, and written communication skills, with the ability to interpret and present complex scientific data clearly

Benefits

Competitive salaries
Excellent benefit package

Company

Arrowhead Pharmaceuticals

twittertwittertwitter
company-logo
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.

Funding

Current Stage
Public Company
Total Funding
$2.45B
Key Investors
Sarepta TherapeuticsSixth StreetSilence Therapeutics
2026-01-07Post Ipo Equity· $200M
2026-01-07Post Ipo Debt· $625M
2024-11-26Post Ipo Equity· $325M

Leadership Team

leader-logo
Christopher Anzalone
President and Chief Executive Officer
leader-logo
Bruce Given
Chief Operating Officer
linkedin
Company data provided by crunchbase